![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Corden Pharma Bergamo S.p.a. Treviglio It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Metronidazole, supported by a 'Valid' Certificate of Suitability (CEP) with the number R2-CEP 1995-052 - Rev 02
This Chemical Type CEP, issued on April 25, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 675 associated with this CEP further emphasizes